CoChat

Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem/progenitor cells in chronic myelogenous leukemia

Open access
Lei, Hu, Xu, Han-Zhang, Shan, Hui-Zhuang, Liu, Meng, Lu, Ying, Fang, Zhi-Xiao, Jin, Jin, Jing, Bo, Xiao, Xin-Hua, Gao, Shen-Meng, Gao, Feng-Hou, Xia, Li, Yang, Li, Liu, Li-Gen, Wang, Wei-Wei, Liu, Chuan-Xu, Tong, Yin, Wu, Yun-Zhao, Zheng, Jun-Ke, Chen, Guo-Qiang, Zhou, Li, Wu, Ying-Li · 2021 · Nature Communications

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.

Abstract

Identifying novel drug targets to overcome resistance to tyrosine kinase inhibitors (TKIs) and eradicating leukemia stem/progenitor cells are required for the treatment of chronic myelogenous leukemia (CML). Here, we show that ubiquitin-specific peptidase 47 (USP47) is a potential target to overcome TKI resistance. Functional analysis shows that USP47 knockdown represses proliferation of CML cells sensitive or resistant to imatinib in vitro and in vivo. The knockout of Usp47 significantly inhibits BCR-ABL and BCR-ABL T315I-induced CML in mice with the reduction of Lin−Sca1+c-Kit+ CML stem/progenitor cells. Mechanistic studies show that stabilizing Y-box binding protein 1 contributes to USP47-mediated DNA damage repair in CML cells. Inhibiting USP47 by P22077 exerts cytotoxicity to CML cells with or without TKI resistance in vitro and in vivo. Moreover, P22077 eliminates leukemia stem/progenitor cells in CML mice. Together, targeting USP47 is a promising strategy to overcome TKI resistance and eradicate leukemia stem/progenitor cells in CML.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-020-20259-0

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 BCR-ABL regulates USP47 through RAS/ERK and STAT5 pathway in CML. a mRNA levels of DUBs in bone marrow (BM) mononuclear cells from primary CML patients compared with normal BM CD34+ cells (CML n = 5, normal n = 3 biologically independent samples). Data are presented as mean ± s.d. *p < 0.05; **p < 0.01; ***p < 0.001, using two-sided Student’s t-test. b USP47 and BCR-ABL protein expression were measured by western blot in primary CML cells at different clinical stages compared with normal BM CD34+ cells. NM normal BM, CP chronic phase, AP accelerated phase, BC blast crisis. c 32DMIGIR and 32DBCR−ABL cells were collected, and the indicated proteins were examined by western blot. d, e Protein (d) and mRNA (e) levels of USP47 in BCR-ABL stably knocked down K562 cells (Sh BCR-ABL) and vector-transfected cells (Ctrl ShRNA) (n = 3 biologically independent samples per group). Data are presented as mean ± s.d. ***p < 0.001, using two-sided Student’s t-test. f K562 cells were treated with IM for 24 h, and the indicated proteins were examined by western blot. g STAT5 knockdown decreased USP47 expression in the K562 cells. h Pan-RAS-IN-1 (RAS inhibitor) and U0126 (ERK inhibitor) decreased USP47 expression in the K562 cells after 24 h of treatment. Source data are provided as a Source Data file.
Fig. 1 BCR-ABL regulates USP47 through RAS/ERK and STAT5 pathway in CML. a mRNA levels of DUBs in bone marrow (BM) mononuclear cells from primary CML patients compared with normal BM CD34+ cells (CML n = 5, normal n = 3 biologically independent samples). Data are presented as mean ± s.d. *p < 0.05; **p < 0.01; ***p < 0.001, using two-sided Student’s t-test. b USP47 and BCR-ABL protein expression were measured by western blot in primary CML cells at different clinical stages compared with normal BM CD34+ cells. NM normal BM, CP chronic phase, AP accelerated phase, BC blast crisis. c 32DMIGIR and 32DBCR−ABL cells were collected, and the indicated proteins were examined by western blot. d, e Protein (d) and mRNA (e) levels of USP47 in BCR-ABL stably knocked down K562 cells (Sh BCR-ABL) and vector-transfected cells (Ctrl ShRNA) (n = 3 biologically independent samples per group). Data are presented as mean ± s.d. ***p < 0.001, using two-sided Student’s t-test. f K562 cells were treated with IM for 24 h, and the indicated proteins were examined by western blot. g STAT5 knockdown decreased USP47 expression in the K562 cells. h Pan-RAS-IN-1 (RAS inhibitor) and U0126 (ERK inhibitor) decreased USP47 expression in the K562 cells after 24 h of treatment. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 2 Knockdown of USP47 inhibits the proliferation of CML cells. a USP47 was silenced in K562, K562R, and KBM5T315I cells using a retroviral transduction system as described in Methods. Viable cells were counted in the transfected cell lines at different times (n = 3 biologically independent samples per group). b Cell cycle was measured in the transfected cell lines on day 3 (n = 3 biologically independent samples per group). c Caspase-3 activity was measured after 3 days of retroviral transfection (n = 3 biologically independent samples per group). d Knockdown efficiency of USP47 in normal human BM CD34+ cells was determined by real-time PCR (n = 3 biologically independent samples per group). e, f The number of colonies (e) and cell viability (f) were measured. Data are mean ± s.d. p-values were analyzed by two-way analysis of variance (ANOVA; a, b) or one-way ANOVA (c–f). *p < 0.05, **p < 0.01; ***p < 0.001; ****p < 0.0001; ns, no significant. Source data are provided as a Source Data file.
Fig. 2 Knockdown of USP47 inhibits the proliferation of CML cells. a USP47 was silenced in K562, K562R, and KBM5T315I cells using a retroviral transduction system as described in Methods. Viable cells were counted in the transfected cell lines at different times (n = 3 biologically independent samples per group). b Cell cycle was measured in the transfected cell lines on day 3 (n = 3 biologically independent samples per group). c Caspase-3 activity was measured after 3 days of retroviral transfection (n = 3 biologically independent samples per group). d Knockdown efficiency of USP47 in normal human BM CD34+ cells was determined by real-time PCR (n = 3 biologically independent samples per group). e, f The number of colonies (e) and cell viability (f) were measured. Data are mean ± s.d. p-values were analyzed by two-way analysis of variance (ANOVA; a, b) or one-way ANOVA (c–f). *p < 0.05, **p < 0.01; ***p < 0.001; ****p < 0.0001; ns, no significant. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 3 Usp47 knockout suppresses the development of BCR-ABL-induced CML in mice. a Genotyping of Usp47 knockout (Usp47−/−) mice by PCR. b The total BM cells from 8-week-old Usp47+/+ and Usp47−/− mice were counted (n = 6 biologically independent samples per group). Data are mean ± s.d. p-values were analyzed by two-sided Student’s t-test. ns, no significant. c Lin−Sca1+ c-kit+ (LSK) cells from 8-week Usp47+/+ and Usp47−/− mice (n = 3 biologically independent samples per group) were measured by FACS. Data are mean ± s.d. p-values were analyzed by two-sided Student’s t-test. ns no significant. d Survival of mice after receiving BCR-ABL-transduced Usp47+/+ or Usp47−/− BM cells (n = 8 biologically independent samples per group). The experiment was repeated three times. ****p < 0.0001, p-value was analyzed by Mantel-Cox-log-rank test. e The size and weight of the spleen in the two groups of mice were shown on day 45 (n = 6 biologically independent samples per group). center lines of the box and whisker plot represent median values, whereas the box edges indicate the 25th and 75th centiles, and the whiskers indicate the minimum and maximum values. f 35 days after transplantation, the percentages of GFP+ and Gr-1+ cells in BM were examined by FACS analysis (upper panel). The morphology of the cells from PB was examined by Wright-Giemsa staining (lower panel). Scale bar, 20 μm. g H&E staining of liver and spleen from the two groups of mice 45 days after transplantation. Scale bars, 200 × , 100 μm; 400 × , 50 μm. h Immunohistochemical staining of liver and spleen with GFP antibody 45 days after transplantation. Scale bars, 200 × , 100 μm; 400 × , 50 μm. i FACS analysis of the GFP+ LSK cells in BM 35 days after transplantation (n = 3 biologically independent samples per group). Data are mean ± s.d. p-values were analyzed by two-sided Student’s t-test. **p < 0.01. Source data are provided as a Source Data file.
Fig. 3 Usp47 knockout suppresses the development of BCR-ABL-induced CML in mice. a Genotyping of Usp47 knockout (Usp47−/−) mice by PCR. b The total BM cells from 8-week-old Usp47+/+ and Usp47−/− mice were counted (n = 6 biologically independent samples per group). Data are mean ± s.d. p-values were analyzed by two-sided Student’s t-test. ns, no significant. c Lin−Sca1+ c-kit+ (LSK) cells from 8-week Usp47+/+ and Usp47−/− mice (n = 3 biologically independent samples per group) were measured by FACS. Data are mean ± s.d. p-values were analyzed by two-sided Student’s t-test. ns no significant. d Survival of mice after receiving BCR-ABL-transduced Usp47+/+ or Usp47−/− BM cells (n = 8 biologically independent samples per group). The experiment was repeated three times. ****p < 0.0001, p-value was analyzed by Mantel-Cox-log-rank test. e The size and weight of the spleen in the two groups of mice were shown on day 45 (n = 6 biologically independent samples per group). center lines of the box and whisker plot represent median values, whereas the box edges indicate the 25th and 75th centiles, and the whiskers indicate the minimum and maximum values. f 35 days after transplantation, the percentages of GFP+ and Gr-1+ cells in BM were examined by FACS analysis (upper panel). The morphology of the cells from PB was examined by Wright-Giemsa staining (lower panel). Scale bar, 20 μm. g H&E staining of liver and spleen from the two groups of mice 45 days after transplantation. Scale bars, 200 × , 100 μm; 400 × , 50 μm. h Immunohistochemical staining of liver and spleen with GFP antibody 45 days after transplantation. Scale bars, 200 × , 100 μm; 400 × , 50 μm. i FACS analysis of the GFP+ LSK cells in BM 35 days after transplantation (n = 3 biologically independent samples per group). Data are mean ± s.d. p-values were analyzed by two-sided Student’s t-test. **p < 0.01. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 4 Silence of Usp47 inhibits BCR-ABLT315I-induced CML and inhibits proliferation of KBMT315I in a xenograft model. a Survival of mice after the transplantation of BCR-ABLT315I-transduced Usp47+/+ or Usp47−/− BM cells (n = 6 biologically independent samples per group). ****p < 0.0001, p-value was analyzed by Mantel-Cox-log-rank test. The experiment was repeated three times. b, c Size (b) and weight (c) of the spleen in the two groups of mice (n = 5 biologically independent samples per group) at 28 days after transplantation. Center lines of the box and whisker plot represent median values, whereas the box edges indicate the 25th and 75th centiles, and the whiskers indicate the minimum and maximum values. d, e At 28 days after transplantation, the morphology of cells from PB (d) was examined by Wright-Giemsa staining; the percentages of GFP+ and Gr-1+ cells (e) in BM were examined by FACS analysis. f H&E staining of the liver and spleen at 28 days after transplantation. Scale bars, 50 μm. g Ctrl shRNA or ShUSP47-2 transfected KBM5T315I cells (n = 8 biologically independent samples per group) were injected into B-NDG mice through the tail vein. ****p < 0.0001, p-value was analyzed by Mantel-Cox-log-rank test. h Size and weight of spleen at day 21 (n = 6 biologically independent samples per group). Center lines of the box and whisker plot represent median values, whereas the box edges indicate the 25th and 75th centiles, and the whiskers indicate the minimum and maximum values. i Infiltration of leukemia cells in the livers of the mice from Fig. 4h. Green arrows indicate infiltrated leukemic cells. Scale bars, 1 cm. j H&E staining of liver and spleen from mice bearing leukemia. Scale bars, 200 × , 100 μm; 400 × , 50 μm. k Immunohistochemical staining with human CD45 antibody in the liver and spleen shown in Fig. 4j. Scale bars, 200 × , 100 μm; 400 × , 50 μm. Data are mean ± s.d. p-values were analyzed by two-sided Student’s t-test (c, h) or Mantel-Cox-log-rank test (a, g). **p < 0.01; ****p < 0.0001. Source data are provided as a Source Data file.
Fig. 4 Silence of Usp47 inhibits BCR-ABLT315I-induced CML and inhibits proliferation of KBMT315I in a xenograft model. a Survival of mice after the transplantation of BCR-ABLT315I-transduced Usp47+/+ or Usp47−/− BM cells (n = 6 biologically independent samples per group). ****p < 0.0001, p-value was analyzed by Mantel-Cox-log-rank test. The experiment was repeated three times. b, c Size (b) and weight (c) of the spleen in the two groups of mice (n = 5 biologically independent samples per group) at 28 days after transplantation. Center lines of the box and whisker plot represent median values, whereas the box edges indicate the 25th and 75th centiles, and the whiskers indicate the minimum and maximum values. d, e At 28 days after transplantation, the morphology of cells from PB (d) was examined by Wright-Giemsa staining; the percentages of GFP+ and Gr-1+ cells (e) in BM were examined by FACS analysis. f H&E staining of the liver and spleen at 28 days after transplantation. Scale bars, 50 μm. g Ctrl shRNA or ShUSP47-2 transfected KBM5T315I cells (n = 8 biologically independent samples per group) were injected into B-NDG mice through the tail vein. ****p < 0.0001, p-value was analyzed by Mantel-Cox-log-rank test. h Size and weight of spleen at day 21 (n = 6 biologically independent samples per group). Center lines of the box and whisker plot represent median values, whereas the box edges indicate the 25th and 75th centiles, and the whiskers indicate the minimum and maximum values. i Infiltration of leukemia cells in the livers of the mice from Fig. 4h. Green arrows indicate infiltrated leukemic cells. Scale bars, 1 cm. j H&E staining of liver and spleen from mice bearing leukemia. Scale bars, 200 × , 100 μm; 400 × , 50 μm. k Immunohistochemical staining with human CD45 antibody in the liver and spleen shown in Fig. 4j. Scale bars, 200 × , 100 μm; 400 × , 50 μm. Data are mean ± s.d. p-values were analyzed by two-sided Student’s t-test (c, h) or Mantel-Cox-log-rank test (a, g). **p < 0.01; ****p < 0.0001. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 5 USP47 interacts with YB-1 and protects it from proteasomal degradation. a Immunoprecipitation with USP47 antibody in K562 cells, the proteins were separated by SDS-PAGE and visualized by Coomassie brilliant blue (G250). b The interaction between endogenous USP47 and YB-1 was analyzed by western blot in K562 and primary CML cells. c Full-length or several deletion constructs of GFP-YB-1 was co-transfected with Flag-USP47 in HEK293T cells. Their interactions were examined by co-IP with anti-GFP antibody and by western blot with anti-Flag antibody. d GFP-YB-1-FL/GFP-YB-1-S2/GFP-YB-1-S3 and HA-ubiquitin plasmids were co-transfected with or without Flag-USP47 into HEK293T cells. YB-1 was co-IP with anti-GFP antibody, and its ubiquitination was measured with Ub antibody by western blot. e Normal and CML BM mononuclear cells were lysed and co-IP with YB-1 antibody, YB-1 ubiquitination was detected with Ub antibody. f Flag-USP47, GFP-YB-1, and GFP-YB-1-mu (K137A, K164A, and K170A) were transfected in HEK293T cells. Their interactions were examined by co-IP with anti-Flag antibody and measured by western blot with anti-GFP antibody. g GFP-YB-1 or GFP-YB-1-mu was transfected with HA-Ub in HEK293T cells. YB-1 ubiquitination in transiently transfected cells was analyzed by co-IP with anti-GFP antibody and western blot with Ub antibody. h USP47 plasmids and empty vectors were transfected into K562 cells. The transfected cells were treated with cycloheximide (CHX, 10 μM) at different times. The indicated proteins were determined by western blot. i, j USP47 knockdown cells or Usp47−/− MEFs were treated with cycloheximide (CHX, 10 μM) at different times together with the control cells, and the indicated proteins were determined by western blot. k Control and USP47 stably knockdown K562 cells were treated with vehicle and MG132 (10 μM) for 4 h. The proteins were then extracted and subjected to western blot. l YB-1 expression in Usp47−/− MEFs was measured by western blot after reintroduction of USP47. Source data are provided as a Source Data file.
Fig. 5 USP47 interacts with YB-1 and protects it from proteasomal degradation. a Immunoprecipitation with USP47 antibody in K562 cells, the proteins were separated by SDS-PAGE and visualized by Coomassie brilliant blue (G250). b The interaction between endogenous USP47 and YB-1 was analyzed by western blot in K562 and primary CML cells. c Full-length or several deletion constructs of GFP-YB-1 was co-transfected with Flag-USP47 in HEK293T cells. Their interactions were examined by co-IP with anti-GFP antibody and by western blot with anti-Flag antibody. d GFP-YB-1-FL/GFP-YB-1-S2/GFP-YB-1-S3 and HA-ubiquitin plasmids were co-transfected with or without Flag-USP47 into HEK293T cells. YB-1 was co-IP with anti-GFP antibody, and its ubiquitination was measured with Ub antibody by western blot. e Normal and CML BM mononuclear cells were lysed and co-IP with YB-1 antibody, YB-1 ubiquitination was detected with Ub antibody. f Flag-USP47, GFP-YB-1, and GFP-YB-1-mu (K137A, K164A, and K170A) were transfected in HEK293T cells. Their interactions were examined by co-IP with anti-Flag antibody and measured by western blot with anti-GFP antibody. g GFP-YB-1 or GFP-YB-1-mu was transfected with HA-Ub in HEK293T cells. YB-1 ubiquitination in transiently transfected cells was analyzed by co-IP with anti-GFP antibody and western blot with Ub antibody. h USP47 plasmids and empty vectors were transfected into K562 cells. The transfected cells were treated with cycloheximide (CHX, 10 μM) at different times. The indicated proteins were determined by western blot. i, j USP47 knockdown cells or Usp47−/− MEFs were treated with cycloheximide (CHX, 10 μM) at different times together with the control cells, and the indicated proteins were determined by western blot. k Control and USP47 stably knockdown K562 cells were treated with vehicle and MG132 (10 μM) for 4 h. The proteins were then extracted and subjected to western blot. l YB-1 expression in Usp47−/− MEFs was measured by western blot after reintroduction of USP47. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 6 YB-1 contributes to USP47-mediated DNA damage repair in CML cells. a YB-1 was silenced in K562, K562R, and KBM5T315I cells with a retroviral transduction system, and viable cells were counted in the transfected cell lines at different times (n = 3 biologically independent samples per group). Data are mean ± s.d. p-values were analyzed by two-way analysis of variance (ANOVA). ****p < 0.0001. b DNA damage-related protein expression was measured by western blot after USP47 knockdown in the K562 and KBM5T315I cells. c GFP+ BM mononuclear cells were collected from Usp47+/+ and Usp47−/− CML mice, and the indicated proteins were examined by western blot. d Immunofluorescence staining of γH2AX foci in the USP47 or YB-1 knockdown K562 cells. Scale bars, 20 μm. e The number of AP sites (DNA damage quantification) was detected in genomic DNA after USP47 knockdown in the K562 and KBM5T315I cells (n = 3 biologically independent samples per group). Data are mean ± s.d. p-values were analyzed by one-way analysis of variance (ANOVA). ***p < 0.001. f Time-course analysis of the USP47 knockdown-induced DNA damage response in K562 cells and cleaved-PARP1 by western blot. g YB-1, PCNA, and TOPO IIα mRNA levels after YB-1 knockdown at day 7 in K562 cells (n = 3 biologically independent samples per group). Data are mean ± s.d. p-values were analyzed by one-way analysis of variance (ANOVA). *p < 0.05; **p < 0.01; ****p < 0.0001. h DNA damage-related protein expression was measured by western blot after YB-1 knockdown in the K562 cells. i The time-course of DNA damage is shown by γH2AX expression after irradiation (IR, 3 Gy) in the control and YB-1 stably knockdown KBM5T315I cells. Band intensity (γH2AX relative to β-actin) is shown by the histogram (n = 3 biologically independent samples per group). Data are mean ± s.d. p-values were analyzed by two-way analysis of variance (ANOVA). ***p < 0.001; ****p < 0.0001. j Exogenous YB-1 protein was expressed in the cell line with stably knocked down USP47, the expression of γH2AX and exogenous YB-1 (GFP tag) was detected by western blot. k The number of AP sites was measured as described above (n = 3 biologically independent samples per group). Data are mean ± s.d. p-values were analyzed by one-way analysis of variance (ANOVA). ***p < 0.001. l γH2AX expression in Usp47−/− MEFs was measured by western blot after the reintroduction of YB-1. m, n USP47 was knocked down in primary CML CD34+ cells, then the cells were cultured in a stem cell colony formation medium. The colonies (m) were counted on day 14 (n = 3 biologically independent samples per group). Data are mean ± s.d. p-values were analyzed by one-way analysis of variance (ANOVA). ***p < 0.001. Immunofluorescence staining of γH2AX foci (n) was performed (n = 3 biologically independent samples per group). Scale bars, 20 μm. Source data are provided as a Source Data file.
Fig. 6 YB-1 contributes to USP47-mediated DNA damage repair in CML cells. a YB-1 was silenced in K562, K562R, and KBM5T315I cells with a retroviral transduction system, and viable cells were counted in the transfected cell lines at different times (n = 3 biologically independent samples per group). Data are mean ± s.d. p-values were analyzed by two-way analysis of variance (ANOVA). ****p < 0.0001. b DNA damage-related protein expression was measured by western blot after USP47 knockdown in the K562 and KBM5T315I cells. c GFP+ BM mononuclear cells were collected from Usp47+/+ and Usp47−/− CML mice, and the indicated proteins were examined by western blot. d Immunofluorescence staining of γH2AX foci in the USP47 or YB-1 knockdown K562 cells. Scale bars, 20 μm. e The number of AP sites (DNA damage quantification) was detected in genomic DNA after USP47 knockdown in the K562 and KBM5T315I cells (n = 3 biologically independent samples per group). Data are mean ± s.d. p-values were analyzed by one-way analysis of variance (ANOVA). ***p < 0.001. f Time-course analysis of the USP47 knockdown-induced DNA damage response in K562 cells and cleaved-PARP1 by western blot. g YB-1, PCNA, and TOPO IIα mRNA levels after YB-1 knockdown at day 7 in K562 cells (n = 3 biologically independent samples per group). Data are mean ± s.d. p-values were analyzed by one-way analysis of variance (ANOVA). *p < 0.05; **p < 0.01; ****p < 0.0001. h DNA damage-related protein expression was measured by western blot after YB-1 knockdown in the K562 cells. i The time-course of DNA damage is shown by γH2AX expression after irradiation (IR, 3 Gy) in the control and YB-1 stably knockdown KBM5T315I cells. Band intensity (γH2AX relative to β-actin) is shown by the histogram (n = 3 biologically independent samples per group). Data are mean ± s.d. p-values were analyzed by two-way analysis of variance (ANOVA). ***p < 0.001; ****p < 0.0001. j Exogenous YB-1 protein was expressed in the cell line with stably knocked down USP47, the expression of γH2AX and exogenous YB-1 (GFP tag) was detected by western blot. k The number of AP sites was measured as described above (n = 3 biologically independent samples per group). Data are mean ± s.d. p-values were analyzed by one-way analysis of variance (ANOVA). ***p < 0.001. l γH2AX expression in Usp47−/− MEFs was measured by western blot after the reintroduction of YB-1. m, n USP47 was knocked down in primary CML CD34+ cells, then the cells were cultured in a stem cell colony formation medium. The colonies (m) were counted on day 14 (n = 3 biologically independent samples per group). Data are mean ± s.d. p-values were analyzed by one-way analysis of variance (ANOVA). ***p < 0.001. Immunofluorescence staining of γH2AX foci (n) was performed (n = 3 biologically independent samples per group). Scale bars, 20 μm. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 7 P22077 shows remarkable toxicity on CML cells and CML leukemia stem/progenitor cells in vitro and in vivo. a–e Peripheral blood mononuclear cells (PBMC) from normal donors (a) (n = 3 samples examined over three independent experiments), CML cell lines (b) (n = 3 cells examined over three independent experiments), and BM mononuclear cells from IM-sensitive (c) (n = 5 samples examined over three independent experiments) and IM-resistant (d) (n = 7 samples examined over three independent experiments) CML patients were treated with different concentrations of P22077 or IM for 48 h. Cell viability was measured by CCK8 assay. e BM mononuclear cells resistance to the second-generation TKIs (dasatinib, nilotinib, bosutinib) from CML patients were treated with P22077 and IM for 48 h (n = 3 samples examined over three independent experiments). Cell viability was measured by CCK8 assay. Data are presented as mean ± s.d. p-values were analyzed by one-way analysis of variance (ANOVA), *p < 0.05; **p < 0.01; ***p < 0.001, ****p < 0.0001. f Primary CML (IM-sensitive), CML-R (IM-resistant) BM mononuclear cells and KBM5T315I cells were treated with P22077 for 48 h. Cell lysates from the indicated cells were extracted and subjected to immunoblotting with indicated antibodies. g P22077 (30 mg/kg/day), IM (50 mg/kg/day), P22077 (30 mg/kg/day) in combination with IM (50 mg/kg/day) or vehicle were given to mice transplanted with KBM5T315I cells by intraperitoneal injection (n = 6 biologically independent samples per group) from day 15 to day 30. **p < 0.01, by Mantel-Cox-log-rank test. h, i Human CD45 cells from CML BM (patient-derived xenograft model) were transplanted into two groups of B-NDG mice. The survival time of the mice (h) (n = 7 biologically independent samples per group) was determined, and the percentages of CD34+CD38− cells in human CD45 cells (i) (n = 3 biologically independent samples per group) from BM were measured. Data are mean ± s.d. p-values were analyzed by Mantel-Cox-log-rank test (h) and two-sided Student’s t-test (i). **p < 0.01; ***p < 0.001. j CD34+ cells derived from normal (n = 3 samples examined over three independent experiments), primary IM-sensitive CML (n = 3 samples examined over three independent experiments), and primary IM-resistant CML BM mononuclear cells (n = 3 samples examined over three independent experiments) were treated with different concentrations of P22077. The colonies were counted on day 14. Scale bars, 100 μm. Data are mean ± s.d. p-values were analyzed by one-way analysis of variance (ANOVA). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001; ns no significant. k Wild-type mice received BCR-ABL retroviral transplantation for 21 days, and the mice were treated with control or P22077 by intraperitoneal injection for 14 days. GFP+LSK cells from the BM of the two groups (n = 6 biologically independent samples per group) were evaluated by FACS. Data are mean ± s.d. p-values were analyzed by two-sided Student’s t-test. ****p < 0.0001. l Wild-type mice received BCR-ABL retroviral transplantation for 21 days, and the mice were treated with IM for 40 days. Mice were divided into two groups (n = 6 biologically independent samples per group). One group received P22077, and the other group received the vehicle and used as the control. After 12 days, the number of GFP+LSK cells in the BM of the mice was examined. Data are mean ± s.d. p-values were analyzed by two-sided Student’s t-test. ****p < 0·0001. Source data are provided as a Source Data file.
Fig. 7 P22077 shows remarkable toxicity on CML cells and CML leukemia stem/progenitor cells in vitro and in vivo. a–e Peripheral blood mononuclear cells (PBMC) from normal donors (a) (n = 3 samples examined over three independent experiments), CML cell lines (b) (n = 3 cells examined over three independent experiments), and BM mononuclear cells from IM-sensitive (c) (n = 5 samples examined over three independent experiments) and IM-resistant (d) (n = 7 samples examined over three independent experiments) CML patients were treated with different concentrations of P22077 or IM for 48 h. Cell viability was measured by CCK8 assay. e BM mononuclear cells resistance to the second-generation TKIs (dasatinib, nilotinib, bosutinib) from CML patients were treated with P22077 and IM for 48 h (n = 3 samples examined over three independent experiments). Cell viability was measured by CCK8 assay. Data are presented as mean ± s.d. p-values were analyzed by one-way analysis of variance (ANOVA), *p < 0.05; **p < 0.01; ***p < 0.001, ****p < 0.0001. f Primary CML (IM-sensitive), CML-R (IM-resistant) BM mononuclear cells and KBM5T315I cells were treated with P22077 for 48 h. Cell lysates from the indicated cells were extracted and subjected to immunoblotting with indicated antibodies. g P22077 (30 mg/kg/day), IM (50 mg/kg/day), P22077 (30 mg/kg/day) in combination with IM (50 mg/kg/day) or vehicle were given to mice transplanted with KBM5T315I cells by intraperitoneal injection (n = 6 biologically independent samples per group) from day 15 to day 30. **p < 0.01, by Mantel-Cox-log-rank test. h, i Human CD45 cells from CML BM (patient-derived xenograft model) were transplanted into two groups of B-NDG mice. The survival time of the mice (h) (n = 7 biologically independent samples per group) was determined, and the percentages of CD34+CD38− cells in human CD45 cells (i) (n = 3 biologically independent samples per group) from BM were measured. Data are mean ± s.d. p-values were analyzed by Mantel-Cox-log-rank test (h) and two-sided Student’s t-test (i). **p < 0.01; ***p < 0.001. j CD34+ cells derived from normal (n = 3 samples examined over three independent experiments), primary IM-sensitive CML (n = 3 samples examined over three independent experiments), and primary IM-resistant CML BM mononuclear cells (n = 3 samples examined over three independent experiments) were treated with different concentrations of P22077. The colonies were counted on day 14. Scale bars, 100 μm. Data are mean ± s.d. p-values were analyzed by one-way analysis of variance (ANOVA). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001; ns no significant. k Wild-type mice received BCR-ABL retroviral transplantation for 21 days, and the mice were treated with control or P22077 by intraperitoneal injection for 14 days. GFP+LSK cells from the BM of the two groups (n = 6 biologically independent samples per group) were evaluated by FACS. Data are mean ± s.d. p-values were analyzed by two-sided Student’s t-test. ****p < 0.0001. l Wild-type mice received BCR-ABL retroviral transplantation for 21 days, and the mice were treated with IM for 40 days. Mice were divided into two groups (n = 6 biologically independent samples per group). One group received P22077, and the other group received the vehicle and used as the control. After 12 days, the number of GFP+LSK cells in the BM of the mice was examined. Data are mean ± s.d. p-values were analyzed by two-sided Student’s t-test. ****p < 0·0001. Source data are provided as a Source Data file.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 68 references

Cited by

See all 146

Metadata

Authors
Lei, H., Xu, H.-Z., Shan, H.-Z., Liu, M., Lu, Y., Fang, Z.-X., Jin, J., Jing, B., Xiao, X.-H., Gao, S.-M., Gao, F.-H., Xia, L., Yang, L., Liu, L.-G., Wang, W.-W., Liu, C.-X., Tong, Y., Wu, Y.-Z., Zheng, J.-K., Chen, G.-Q., Zhou, L., & Wu, Y.-L.
Affiliations
Shanghai Jiao Tong University (CN)
Corresponding author
  • Chen, Guo-Qiang
  • Zhou, Li
Venue
Nature Communications
Published
2021-01-04
Volume
12
Issue
1
Pages
51-51
ISSN
2041-1723 (ISSN-L)
OpenAlex
W3118511950
Cited by
146
References
68
Citations by year
2026: 8 · 2025: 17 · 2024: 15 · 2023: 10 · 2022: 15 · 2021: 81
FWCI
19.77
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Natural Science Foundation of China (81700475, 81670139, 81570112)
Topics
  • Health Sciences › Medicine › Hematology › Chronic Myeloid Leukemia Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
  • Health Sciences › Medicine › Hematology › Chronic Lymphocytic Leukemia Research
Keywords
USP47, chronic myeloid leukemia, tyrosine kinase inhibitor resistance, imatinib resistance, BCR-ABL, T315I mutation, YB-1, DNA repair, ubiquitin-specific peptidase, therapeutic target
MeSH terms
Animals, DNA Damage, DNA Repair, Humans, Protein Binding, RNA, Messenger, Thiophenes, Neoplastic Stem Cells, Signal Transduction, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Gene Expression Regulation, Leukemic, Fusion Proteins, bcr-abl, Mice, Knockout, ras Proteins, Drug Resistance, Neoplasm, K562 Cells, Xenograft Model Antitumor Assays, Ubiquitin Thiolesterase, Proteasome Endopeptidase Complex, Protein Kinase Inhibitors, Extracellular Signal-Regulated MAP Kinases, Cell Proliferation, STAT5 Transcription Factor, Mice, Y-Box-Binding Protein 1, Protein Stability, Proteolysis, Ubiquitin-Specific Proteases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem/progenitor cells in chronic myelogenous leukemia. https://app.cochat.ai/papers/10.1038/s41467-020-20259-0
The paper
Lei, H., Xu, H.-Z., Shan, H.-Z., Liu, M., Lu, Y., Fang, Z.-X., Jin, J., Jing, B., Xiao, X.-H., Gao, S.-M., Gao, F.-H., Xia, L., Yang, L., Liu, L.-G., Wang, W.-W., Liu, C.-X., Tong, Y., Wu, Y.-Z., Zheng, J.-K., . . . Wu, Y.-L. (2021). Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem/progenitor cells in chronic myelogenous leukemia. Nature Communications. https://doi.org/10.1038/s41467-020-20259-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.